UCPVax
- Generic Name
- UCPVax
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
- First Posted Date
- 2020-02-21
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 67
- Registration Number
- NCT04280848
- Locations
- 🇫🇷
Hôpital Saint-Louis, Paris, France
🇫🇷CHU Bordeaux, Bordeaux, France
🇫🇷CHU Besançon, Besançon, France
Universal Cancer Peptide-based Vaccination in Metastatic NSCLC
- First Posted Date
- 2016-06-29
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 82
- Registration Number
- NCT02818426
- Locations
- 🇫🇷
Centre Hospitalier Régional Universitaire de Besançon, Besancon, France
🇫🇷Hôpitaux Universitaires de Strasbourg, Strasbourg, France
🇫🇷Centre Georges François Leclerc, Dijon, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath